|
|
||||||||
and Infection-Induced Intestinal Inflammation1




* Department of Pathobiology, University of Pennsylvania, Philadelphia, PA 19104;
Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591; and
Amgen, Thousand Oaks, CA 91320
| Abstract |
|---|
|
|
|---|
production and intestinal inflammation. In contrast, infected RELMβ–/– mice exhibited a significantly reduced expression of parasite-specific CD4+ T cell-derived IFN-
and TNF-
and failed to develop Trichuris-induced intestinal inflammation. In in vitro T cell differentiation assays, recombinant RELMβ activated macrophages to express MHC class II and secrete IL-12/23p40 and enhanced their ability to mediate Ag-specific IFN-
expression in CD4+ T cells. Taken together, these data suggest that goblet cell-macrophage cross-talk, mediated in part by RELMβ, can promote adaptive CD4+ T cell responses and chronic inflammation following intestinal helminth infection. | Introduction |
|---|
|
|
|---|
RELMβ belongs to the family of resistin-like molecules, a group of small, cysteine-rich secreted mammalian proteins (9, 10, 11, 12). RELMβ is highly expressed in several disease settings including murine models of helminth infection, cystic fibrosis, and inflammatory bowel disease (7, 13, 14, 15, 16). We previously reported that exposure to the intestinal-dwelling helminth pathogen Trichuris promotes RELMβ expression and that RELMβ could disrupt parasite sensory functions in an in vitro assay, suggesting a potential antiparasite effector function (13). More recent studies suggested an additional role for RELMβ in promoting intestinal inflammation both in response to chemical-induced colonic injury and in a genetic model of ileitis (7, 15, 17). However, whether RELMβ is necessary for resistance to Trichuris or can directly influence innate or adaptive immune cell function following enteric infection remains unknown. To address this question, we used RELMβ–/– mice in both acute and chronic Trichuris infection. Trichuris is a natural parasite of mice and provides a well-established model where resistance to infection is critically dependent on the development of an adaptive Th2 cytokine response, while susceptibility is associated with a Th1 cytokine response (18, 19, 20). In C57BL/6 mice, the development of an acute or chronic Trichuris infection is achieved through manipulation of the infection dose (21). In response to high-dose infection, a parasite-specific protective Th2 cytokine response is generated, allowing efficient parasite expulsion while low-dose infection, which is more representative of a natural infection in humans, mediates the generation of a Th1 cytokine-dominated response and chronic parasite establishment (21, 22, 23, 24, 25).
In this study, using RELMβ–/– mice in acute infection with Trichuris, we demonstrate that goblet cell-derived RELMβ is not required for the generation of a protective Th2 cytokine response and the expulsion of Trichuris. However, in low-dose Trichuris infection, RELMβ–/– mice exhibited reduced expression of parasite-specific IFN-
, failed to develop infection-induced intestinal inflammation, and did not develop persistent infection. In vitro, recombinant RELMβ augmented Th1 cell differentiation through the direct activation of macrophages to up-regulate MHC class II expression and production of IL-12/23p40. Collectively, these data identify dual functions for RELMβ in enhancing Trichuris-induced intestinal inflammation and adaptive CD4+ Th1 cell responses, and support a role for intestinal goblet cells in influencing innate and adaptive immune responses through the regulation of intestinal macrophage function.
| Materials and Methods |
|---|
|
|
|---|
RELMβ–/– mice were generated as described previously (15). C57BL/6 mice were obtained from The Jackson Laboratory. Mice transgenic for the OVA323–339-specific TCR (OT-II) on a C57BL/6 background were bred and maintained in a specific pathogen-free environment. All experiments were performed following the guidelines of the University of Pennsylvania Institutional Animal Care and Use Committee. Trichuris was maintained in genetically susceptible animals. Isolation of Trichuris excretory-secretory Ag and eggs was performed as described previously (26). Mice were infected orally with 30 (low-dose) or 200 (high-dose) embryonated eggs, and parasite burdens in ceca were determined on various days after infection. For BrdU incorporation assays, mice were injected i.p. with 0.8 mg of BrdU (Sigma-Aldrich) in PBS at 1 and 3 days before sacrifice.
In vitro T cell differentiation assays
Splenocytes were isolated from naive animals, labeled with CFSE (5 µg/ml; Molecular Probes) and cultured for 4 days with anti-CD3/anti-CD28 (1 µg/ml each, eBioscience) in the presence or absence of rRELMβ (1–10 µg/ml; PeproTech). CD4+ T cells, purified by negative depletion using homegrown supernatants (cell lines RAE, 2.43, M5114, and 2.4G2) and goat anti-rat magnetic beads (Qiagen) allowing >90% purity were CFSE labeled and activated with plate-bound anti-CD3/anti-CD28 in the presence or absence of rRELMβ (10 µg/ml). Four days later, cells were stimulated with PMA (50 ng/ml), ionomycin (500 ng/ml), and brefeldin A (10 µg/ml) (all from Sigma-Aldrich). Cells were surface stained with CD4, followed by intracellular staining with IFN-
and IL-4 (all from eBioscience) allowing analysis by flow cytometry. Cell-free supernatants were harvested and analyzed for cytokine secretion by ELISA. For macrophage/dendritic cell (DC) coculture assays, BM macrophages and DC were generated as described previously (3, 27). Macrophages or DC were cultured overnight with medium alone or OVA protein (500 µg/ml; Worthington) in the presence or absence of rRELMβ (10 µg/ml) followed by two washes with warm medium to remove stimulus and coculture with CFSE-labeled OTII CD4+T cells, purified by negative depletion as above, at a 4:1 T cell:macrophage ratio. Four days later, cells were pulsed with PMA, ionomycin, and brefeldin A as above, followed by cell recovery for flow cytometric analysis, and recovery of supernatants for cytokine analysis by ELISA.
Macrophage activation assays
For analysis of MAPK signaling, 1 x 106 BM macrophages were pulsed with rRELMβ (40 µg/ml), followed by lysis at time points indicated in HNTG buffer (0.1% Triton X-100, 20 mM HEPES, 10% glycerol, 150 mM NaCl, and 1 mM DTT, pH7.5) supplemented with a mixture of protease inhibitors (Roche). Whole cell lysates were resolved by SDS-PAGE, followed by immunoblotting with antiphosphorylated ERK1/2 and β-actin (all from Cell Signaling Technology). For analysis of surface activation markers and cytokine secretion, 1 x 106 macrophages were cultured overnight in medium alone, treated with rRELMβ (10 µg/ml) or LPS (100 ng/ml) followed by recovery of supernatants for measurement of cytokine secretion by ELISA and flow cytometric analysis of cells with Abs to F4/80 and MHC class II (all from eBioscience).
Analysis of Trichuris-induced immune responses
Mesenteric lymph node (MLN) or cecal patch cells from naive or infected mice were pulsed for 4–6 h with PMA, ionomycin, and brefeldin A followed by intracellular cytokine analysis by flow cytometry. For BrdU incorporation, MLN cells were stained ex vivo according to the BD Pharmingen BrdU staining protocol. For Ag-specific cytokine responses, MLN cells were plated in medium alone or in the presence of Trichuris ES Ag (50 µg/ml). Cell-free supernatants were harvested and analyzed for cytokine secretion by ELISA. Trichuris-specific IgG1 and IgG2a were measured by ELISA of serum dilutions from naive and infected mice using Trichuris Ag-coated plates (5 µg/ml).
RELMβ responses and histological analysis
RELMβ (Retnlb) gene expression analysis was performed by intestinal tissue RNA isolation using the Qiagen RNeasy Kit (Qiagen) followed by cDNA generation and real-time PCR using SYBR Green technology (Applied Biosystems) with RELMβ- and β-actin-customized primers (Qiagen). Reactions were run on the GeneAmp 5700 Sequence Detection System (Applied Biosystems). Similar to RELMβ, expression of Il18, Il12a, Ifng, and Il4 in the colons was measured using customized primers. Western blot analysis was performed as described previously (13). In brief, 20 µg of protein was isolated from fecal pellets and resolved by SDS-PAGE followed by immunoblotting for RELMβ with a polyclonal rabbit anti-murine RELMβ Ab. For immunofluorescence and histological analysis, paraffin-embedded 4% paraformaldehyde (PFA)-fixed cecal tissue sections were stained for RELMβ as described previously (13) or with H&E or periodic acid-Schiff (PAS)/Alcian blue.
Statistical analysis
Results, representative of three or more separate experiments, represent the mean ± SEM of individual animals or conditions. Statistical significance was determined by the two-tailed Students t test. Results were considered significant when p < 0.05.
| Results |
|---|
|
|
|---|
Our previous studies demonstrated that RELMβ was expressed following infection with the gastrointestinal helminth Trichuris and that in vitro RELMβ could bind to the parasite sensory apparatus and inhibit chemotaxis (13). To investigate a potential antiparasitic effector function for RELMβ in vivo, wild-type (WT) and RELMβ–/– mice were infected with 200 Trichuris eggs, and the kinetics of parasite clearance were examined. By day 15 after infection, both WT and RELMβ–/– mice exhibited equivalent worm expulsion and sterile immunity was achieved by day 21 in both genotypes (Fig. 1A). Since RELMβ was recently implicated in promoting mucus secretion (28), an important antiparasitic effector response (29), we examined goblet cell responses in naive and Trichuris-infected WT and RELMβ–/– mice. Histological analysis of PAS/Alcian blue-stained cecal tissue sections revealed that Trichuris infection induced equivalent intestinal crypt elongation and mucus production by goblet cells in both WT and RELMβ–/– mice, demonstrating that RELMβ deficiency did not noticeably alter goblet cell responses. Additionally, worm expulsion was associated with the equivalent expansion of CD4+ T cells from the draining MLN, examined by BrdU incorporation (Fig. 1C), and the induction of IL-4 mRNA in the colons of infected WT and RELMβ–/– mice at day 21 postinfection (Fig. 1D). Consistent with a polarized Th2 cytokine response, infected WT mice did not exhibit elevated levels of IFN-
mRNA in the intestine compared with naive mice (Fig. 1E). Strikingly, basal levels of IFN-
mRNA were reduced in the colons of infected RELMβ–/– mice (Fig. 1E). Taken together, these findings demonstrate that although goblet cell-derived RELMβ is not essential for the development of infection-induced Th2 cytokine responses or sterile immunity, it may influence IFN-
responses in the intestinal microenvironment.
|
RELMβ was recently implicated in influencing host inflammatory responses. Specifically, we and others showed that RELMβ–/– mice exhibit reduced intestinal inflammation in a murine model of colitis (7, 15). Based on these findings, and the reduced levels of IFN-
mRNA in the colons of infected RELMβ–/– mice (Fig. 1E), we hypothesized that goblet cell-derived RELMβ may influence infection-induced inflammatory responses during chronic infection. Infection with a low dose of Trichuris results in the production of IFN-
, which promotes persistent infection in normally resistant hosts (21, 23). Following exposure to Trichuris, RELMβ (Retnlb) mRNA levels in the large intestine were up-regulated 25- and 60-fold over levels in naive mice at days 22 and 34 postinfection, respectively (Fig. 2A). Western blot analysis of luminally secreted RELMβ in the feces of infected mice revealed that RELMβ secretion was detectable by day 17 and sustained at day 34 (Fig. 2B, upper panel), and immunofluorescent microscopy analysis demonstrated that goblet cells were the cellular source of RELMβ in chronically infected mice (Fig. 2B, lower panel). To test whether RELMβ could influence expression of proinflammatory cytokines and the development of persistent Trichuris infection, WT and RELMβ–/– mice were infected with low-dose Trichuris. At day 22 after infection, WT and RELMβ–/– mice displayed similar parasite burdens (Fig. 2C). Ex vivo analysis of CD4+ T cells isolated from the cecal patch of naive and infected WT mice revealed an infection-induced elevation in the frequency of CD4+ T cells producing IFN-
and TNF-
(Fig. 2, D and E, top panels, italics). This included an 8-fold increase in the frequency of IFN-
-positive CD4+ T cells and a 2.5-fold increase in the frequency of TNF-
-positive CD4+ T cells. In addition to increased frequencies of cytokine-positive cells, infected WT mice exhibited elevated levels of IFN-
and TNF-
produced per cell, as indicated by an elevation in mean fluorescent intensity (MFI) values (Fig. 2, D and E, top panels, bold). In contrast, the frequency and MFI of CD4+ T cells producing IFN-
and TNF-
were reduced in infected RELMβ–/– mice compared with WT mice (Fig. 2, D and E, bottom panels). This included a 4-fold reduction in the percentage of IFN-
-positive CD4+ T cells and a 2-fold reduction in TNF-
-positive CD4+ T cells compared with CD4+ T cells in infected WT mice. Upon Ag-specific restimulation, the MLN cells from infected RELMβ–/– mice also secreted significantly lower levels of IFN-
and TNF-
than cells isolated from infected WT mice (Fig. 2F). Associated with the reduction in proinflammatory cytokine expression, infected RELMβ–/– mice also exhibited significantly reduced Trichuris-specific IgG2a Ab titers but elevated levels of Trichuris-specific IgG1 (Fig. 2G), indicative of a switch from a nonprotective type 1 response to a protective type 2 response in the absence of RELMβ. Given that IFN-
and TNF-
can promote intestinal inflammation (30), we sought to test the hypothesis that RELMβ–/– mice may exhibit less severe infection-induced intestinal inflammation than WT mice. Histological analysis of H&E-stained cecal tissue revealed that WT mice developed severe infection-induced intestinal inflammation characterized by edema, influx of inflammatory cells to the lamina propria, and thickening of the muscularis (Fig. 2H). In contrast, despite similar levels of infection (Fig. 2C), infected RELMβ–/– mice did not exhibit demonstrable intestinal inflammation in comparison to naive controls. Taken together, these data implicate a role for RELMβ in promoting IFN-
responses and infection-induced intestinal inflammation.
|
Expression of IFN-
is associated with the establishment of chronic Trichuris infection and intestinal inflammation (21, 23, 31). Given the striking reduction in IFN-
levels in infected RELMβ–/– mice at day 22 after infection, we sought to test the hypothesis that RELMβ–/– mice may be resistant to establishment of chronic infection. WT and RELMβ–/– mice were infected with low-dose Trichuris and sacrificed at day 34 for measurement of parasite burdens. Although WT mice harbored persistent infection, 10 of 12 RELMβ–/– mice had cleared infection (Fig. 3A). Resistance to chronic infection was associated with a significant reduction in IFN-
mRNA expression in the colon of infected RELMβ–/– mice (Fig. 3B). Consistent with reduced Th1 cell responses, we observed a significant reduction in IL-12p40 protein in the serum of infected RELMβ–/– mice (Fig. 3C). Ex vivo analysis of the MLN cells from infected mice revealed that RELMβ–/– mice had a significantly reduced frequency of IFN-
+CD4+ T cells in comparison to WT mice (Fig. 3D). Finally, infected RELMβ–/– mice exhibited minimal infection-induced inflammation in comparison to WT mice (Fig. 3E). Taken together, these data implicate goblet cell-derived RELMβ in the promotion of chronic Trichuris infection, expression of proinflammatory cytokines, and the development of severe intestinal inflammation.
|
expression in CD4+ T cells
Given the striking reduction in IFN-
expression in Trichuris-infected RELMβ–/– mice, we sought to test the hypothesis that RELMβ could directly influence T cell proliferation or IFN-
production. CFSE-labeled splenocytes from naive C57BL/6 mice were stimulated with anti-CD3/anti-CD28 for 4 days in the presence or absence of increasing doses of rRELMβ. rRELMβ treatment had no effect on proliferation or cytokine production in unstimulated CD4+ T cells, demonstrating that rRELMβ could not initiate T cell proliferation or Th1 cell differentiation (data not shown). However, following polyclonal stimulation, rRELMβ treatment resulted in a dose-dependent augmentation of IFN-
production by CD4+ T cells (Fig. 4A; frequency of proliferating cells expressing IFN-
denoted in upper left corner). The effect of rRELMβ on IFN-
expression was independent of any effects on T cell proliferation (Fig. 4A, frequency of CFSE dim proliferating cells denoted in upper right corner). At maximal concentration, rRELMβ treatment resulted in a 2.2-fold up-regulation in the frequency of proliferating CD4+ T cells that expressed IFN-
(Fig. 4A, upper left italics) and a greater than 2-fold increase in the amount of IFN-
produced per cell as determined by the increase in MFI (Fig. 4A, bold). Finally, the dose-dependent elevation in IFN-
secretion following treatment with rRELMβ was confirmed by ELISA (Fig. 4B). It is important to note that since the rRELMβ utilized was bacterially derived, the concentrations of protein used in vitro (1–10 µg/ml) may not reflect the concentration of native RELMβ in vivo.
|
through effects on accessory cells, BM-derived DC and macrophages were pulsed with OVA protein in the presence or absence of rRELMβ, followed by coculture for 4 days with CFSE-labeled OVA-specific CD4+ T cells. OVA-pulsed DC and macrophages promoted CD4+ T cell proliferation and IFN-
production, as monitored by CFSE dilution and IFN-
staining, demonstrating Ag-specific helper T cell differentiation (Fig. 4, C and E, middle panel). Although rRELMβ treatment had no noticeable effect on the ability of DC to drive Ag-specific T cell proliferation and IFN-
production (Fig. 4, C, right panel, and D), treatment of OVA-pulsed macrophages with rRELMβ augmented their ability to drive Th1 cell differentiation. This included a 1.7-fold increase in the percentage of IFN-
-positive CD4+ T cells (Fig. 4E, italic), a 1.6-fold augmentation in the amount of IFN-
expressed per cell (Fig. 4E, bold), and elevated secretion of IFN-
(Fig. 4F). Taken together, these results identify that goblet cell-derived RELMβ can augment Th1 cell differentiation in vitro through selective regulatory effects on macrophages. Furthermore, they suggest that one mechanism underlying reduced Th1 cell responses in RELMβ–/– mice may be through dysregulated macrophage responses. RELMβ activates macrophages to express MHC class II and proinflammatory cytokines
To examine the mechanism through which rRELMβ-treated macrophages augmented CD4+ Th1 cell responses, BM macrophages were stimulated with rRELMβ. rRELMβ treatment of macrophages induced ERK1/2 phosphorylation (Fig. 5A), demonstrating that macrophages are responsive to RELMβ. rRELMβ-treated macrophages also exhibited increased surface expression of MHC class II (Fig. 5B) and significant elevation in the secretion of TNF-
(Fig. 5C), IL-6 (Fig. 5D), and IL-12/23p40 (Fig. 5E). Taken together, these in vitro studies suggest that one mechanism by which rRELMβ augments CD4+ Th1 cell responses is through direct activation of macrophages to up-regulate MHC class II and IL-12/23p40 and provide a likely basis for the reduced Th1 responses and resistance to chronic infection and intestinal inflammation observed in Trichuris-infected RELMβ–/– mice (Fig. 6).
|
|
| Discussion |
|---|
|
|
|---|
production (36), thus increased IL-12 levels could influence previously activated T cells recruited into the lamina propria. As yet, there is no evidence that in addition to luminal secretion, RELMβ is secreted basolaterally. However, macrophage exposure to RELMβ may occur from a breach in the integrity of the IEC barrier due to colonic injury or through direct macrophage sampling of the luminal contents in a similar manner to lamina propria DC (37, 38).
Most gastrointestinal helminth infections provoke polarized Th2 cytokine responses, and we and others have previously shown that maximal Th2 cytokine production is associated with RELMβ expression (13, 14). In this study, we show that RELMβ expression is also induced and maintained in a Th1 cytokine-biased setting following establishment of chronic Trichuris infection, where it can act as a susceptibility factor by promoting CD4+ Th1 cell responses, chronic infection, and intestinal inflammation. Sequence analysis of the RELMβ promoter has revealed that in addition to STAT6-responsive elements implicating regulation by Th2 cytokines, RELMβ expression may also be regulated by Cdx2 and NF
B signaling, broadening the scope of factors that induce RELMβ (14, 39). Indeed, colonization of the intestine with commensal bacteria can promote RELMβ expression (39). Since Trichuris adult parasites actively embed within IEC (40), the resulting damage to this barrier may allow exposure to commensal bacteria and subsequent RELMβ expression. Supporting this hypothesis, LPS treatment of human goblet cell lines up-regulates RELMβ expression (39). Intriguingly, mice deficient in TLR4 and Myd88 signaling exhibit a similar phenotype to RELMβ–/– mice and are resistant to chronic Trichuris infection (22). Our findings implicate that RELMβ expression may be downstream of TLR4 signaling, potentially induced following exposure to commensal bacteria, and may provide the link between TLR4 signaling and the establishment of chronic Trichuris infection. Although RELMβ expression is detrimental to the host and promotes both parasite establishment and intestinal inflammation, this goblet cell-specific gene may have evolved to protect the intestinal barrier from invasion of both commensal bacteria as well as other intestinal pathogens that may require an adaptive Th1 cytokine response for clearance. Notwithstanding this, these findings support a critical role for IEC-macrophage interactions in shaping CD4+ T cell responses in the gut and suggest that the manipulation of goblet cell differentiation or RELMβ expression may offer therapeutic prospects for the treatment of infection-induced intestinal inflammation as well as other mucosal inflammatory diseases associated with dysregulated T cell responses.
| Acknowledgments |
|---|
| Disclosures |
|---|
|
|
|---|
| Footnotes |
|---|
1 This work was supported by National Institutes of Health Grants AI61570 and AI74878 (to D.A.), the Burroughs Wellcome Funds Investigator in Pathogenesis of Infectious Disease Award (to D.A.), the Crohns and Colitis Foundation of Americas William and Shelby Modell Family Foundation Research Award (to D.A.), and pilot grants from the University of Pennsylvania Center for Infectious Diseases and University Research Fund (to D.A.). C.Z. is funded by the Irvington Institute Fellowship Program of the Cancer Research Institute. ![]()
2 Address correspondence and reprint requests to Dr. David Artis or Dr. Meera G. Nair, Department of Pathobiology, University of Pennsylvania, Room 314, Hill Pavilion, 380 South University Avenue, Philadelphia, PA 19104. E-mail addresses: dartis{at}vet.upenn.edu or nairmg{at}vet.upenn.edu ![]()
3 Abbreviations used in this paper: IEC, intestinal epithelial cell; RELMβ, resistin-like molecule β; BM, bone marrow; MLN, mesenteric lymph node; WT, wild type; MFI, mean fluorescent intensity; DC, dendritic cell. ![]()
Received for publication April 28, 2008. Accepted for publication July 25, 2008.
| References |
|---|
|
|
|---|
-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 435: 959-963. [Medline]
and mucosal T helper-1 cytokines in the pathogenesis of Crohns disease. J. Immunol. 159: 6276-6282. [Abstract]
. Exp. Parasitol. 92: 144-153. [Medline]Related articles in The JI:
This article has been cited by other articles:
![]() |
M. R. Hepworth and R. K. Grencis Disruption of Th2 Immunity Results in a Gender-Specific Expansion of IL-13 Producing Accessory NK Cells during Helminth Infection J. Immunol., September 15, 2009; 183(6): 3906 - 3914. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Krimi, P. Letteron, P. Chedid, C. Nazaret, R. Ducroc, and J.-C. Marie Resistin-Like Molecule-{beta} Inhibits SGLT-1 Activity and Enhances GLUT2-Dependent Jejunal Glucose Transport Diabetes, September 1, 2009; 58(9): 2032 - 2038. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Nair, Y. Du, J. G. Perrigoue, C. Zaph, J. J. Taylor, M. Goldschmidt, G. P. Swain, G. D. Yancopoulos, D. M. Valenzuela, A. Murphy, et al. Alternatively activated macrophage-derived RELM-{alpha} is a negative regulator of type 2 inflammation in the lung J. Exp. Med., April 13, 2009; 206(4): 937 - 952. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |